A Look At Blackbaud (BLKB) Valuation As Development Agent AI Tool Reaches General Availability
Blackbaud, Inc. BLKB | 38.03 | +1.28% |
Blackbaud (BLKB) just rolled out its Development Agent to Raiser’s Edge NXT customers in the U.S., introducing an AI-powered teammate that can autonomously manage donor outreach under human oversight.
Despite rolling out the Development Agent and broadening its AI toolkit, Blackbaud’s 30 day share price return of 10.47% and year to date share price return of 26.18% decline sit alongside a 1 year total shareholder return of 31.23% decline. This points to fading momentum in the stock even as product news continues.
If this kind of AI driven donor tool has your attention, it could be worth widening your screen to other AI names through our dedicated small cap list of 64 profitable AI stocks that aren't just burning cash
So with Blackbaud trading at a discount to both its own estimated intrinsic value and the average analyst target, while its long term returns remain under pressure, are you looking at an undervalued AI player or at a market that already reflects future growth?
Most Popular Narrative: 26.5% Undervalued
With Blackbaud at a last close of $43.94 versus a widely followed fair value estimate of $59.8, the narrative centers on earnings power supported by measured growth and margins.
The shift toward cloud-based SaaS subscription models and improvements in operational efficiency, including automation and AI-driven internal initiatives, are lowering costs and improving gross and net margins, providing significant leverage to long-term earnings growth.
Curious what kind of revenue runway and margin profile sit behind that valuation gap? The core thesis hinges on steady top line expansion, rising profitability, and a future earnings multiple that assumes disciplined execution rather than a high growth story.
Result: Fair Value of $59.8 (UNDERVALUED)
However, this hinges on Blackbaud keeping its AI products competitive while managing margin pressures from ongoing security, compliance, and R&D spending, which could squeeze earnings power.
Next Steps
With both risks and rewards in play, do you feel the balance of sentiment fits your view, or is the market missing something important? Take a closer look at the full breakdown of 5 key rewards and 2 important warning signs
Looking for more investment ideas?
If Blackbaud has sharpened your focus on quality and price, do not stop here. Widen your search with targeted stock lists built to surface specific traits.
- Target potential mispriced opportunities by scanning a curated set of 49 high quality undervalued stocks that pair fundamentals with attractive valuations.
- Prioritise resilience and capital strength by checking companies filtered through our solid balance sheet and fundamentals stocks screener (42 results).
- Hunt for early stage potential by reviewing the 33 elite penny stocks with strong financials that stand out on financial quality, not just a low share price.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
